Phytic acid protects against 6-hydroxydopamine-induced dopaminergic neuron apoptosis in normal and iron excess conditions in a cell culture model

Parkinson's Disease

Volumn , Issue , 2011, Pages

  Xu, Qi ^a   Kanthasamy, Anumantha G ^b   Reddy, Manju B ^b  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; IRON; OXIDOPAMINE; PHYTIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA FRAGMENTATION; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; MESENCEPHALON; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

EID: 79953268470     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.4061/2011/431068     Document Type: Article

References (36)

1. Scheife R. T., Schumock G. T., Burstein A., Gottwald M. D., Luer M. S., Impact of Parkinson's disease and its pharmacologic treatment on quality of life and economic outcomes American Journal of Health-System Pharmacy 2000 57 10 953 962 (Pubitemid 30365636)
2. Betarbet R., Sherer T. B., Timothy Greenamyre J., Animal models of Parkinson's disease BioEssays 2002 24 4 308 318 (Pubitemid 34305686)
3. Jenner P., Hunot., Olanow., Beal., Kordower., Tatton., Schapira., Oxidative stress in Parkinson's disease Annals of Neurology 2003 53 3 S26 S38
4. Reddy M. B., Clark L., Iron, oxidative stress, and disease risk Nutrition Reviews 2004 62 3 120 124 (Pubitemid 38436811)
5. Crichton R. R., Wilmet S., Legssyer R., Ward R. J., Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells Journal of Inorganic Biochemistry 2002 91 1 9 18 (Pubitemid 34727756)
6. Berg D., Iron in neurodegenerative disorders Neurotoxicity Research 2002 4 7-8 637 653 (Pubitemid 35385963)
7. Pollitt E., Leibel R. L., Iron deficiency and behavior Journal of Pediatrics 1976 88 3 372 381
8. Double K. L., Gerlach M., Youdim M. B. H., Riederer P., Impaired iron homeostasis in Parkinson's disease Journal of Neural Transmission, Supplement 2000 60 37 58 (Pubitemid 32037184)
9. Zhang X., Xie W., Qu S., Pan T., Wang X., Le W., Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration Biochemical and Biophysical Research Communications 2005 333 2 544 549 (Pubitemid 40848325)
10. Bharath S., Hsu M., Kaur D., Rajagopalan S., Andersen J. K., Glutathione, iron and Parkinson's disease Biochemical Pharmacology 2002 64 5-6 1037 1048 (Pubitemid 35232279)
11. Vucenik I., Shamsuddin A. M., Protection against cancer by dietary IP and inositol Nutrition and Cancer 2006 55 2 109 125 (Pubitemid 44719624)
12. Reddy M. B., Hurrell R. F., Juillerat M. A., Cook J. D., The influence of different protein sources on phytate inhibition of nonheme-iron absorption in humans American Journal of Clinical Nutrition 1996 63 2 203 207 (Pubitemid 26036241)
13. Shamsuddin A. M., Vucenik I., Cole K. E., IP: a novel anti-cancer agent Life Sciences 1997 61 4 343 354
14. Vucenik I., Tomazic V. J., Fabian D., Shamsuddin A. M., Antitumor activity of phytic acid (inositol hexaphosphate) in murine transplanted and metastatic fibrosarcoma, a pilot study Cancer Letters 1992 65 1 9 13
15. Latchoumycandane C., Anantharam V., Kitazawa M., Yang Y., Kanthasamy A., Kanthasamy A. G., Protein kinase C is a key downstream mediator of manganese-induced apoptosis in dopaminergic neuronal cells Journal of Pharmacology and Experimental Therapeutics 2005 313 1 46 55 (Pubitemid 40411326)
16. Kaul S., Kanthasamy A., Kitazawa M., Anantharam V., Kanthasamy A. G., Caspase-3 dependent proteolytic activation of protein kinase C mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration European Journal of Neuroscience 2003 18 6 1387 1401 (Pubitemid 37215094)
17. Xu Q., Kanthasamy A. G., Reddy M. B., Neuroprotective effect of the natural iron chelator, phytic acid in a cell culture model of Parkinson's disease Toxicology 2008 245 1-2 101 108
18. Yang Y., Kaul S., Zhang D., Anantharam V., Kanthasamy A. G., Suppression of caspase-3-dependent proteolytic activation of protein kinase C by small interfering RNA prevents MPP-induced dopaminergic degeneration Molecular and Cellular Neuroscience 2004 25 3 406 421 (Pubitemid 38366406)
19. Prasad K. N., Cole W. C., Kumar B., Multiple antioxidants in the prevention and treatment of Parkinson's disease Journal of the American College of Nutrition 1999 18 5 413 423 (Pubitemid 29455713)
20. Pinero D. J., Connor J. R., Iron in the brain: an important contributor in normal and diseased states Neuroscientist 2000 6 6 435 453
21. Kaur D., Andersen J. K., Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility? Aging Cell 2002 1 1 17 21
22. Turnbull S., Tabner B. J., El-Agnaf O. M. A., Moore S., Davies Y., Allsop D., -synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro Free Radical Biology and Medicine 2001 30 10 1163 1170 (Pubitemid 32441842)
23. Hasegawa T., Matsuzaki M., Takeda A., Kikuchi A., Akita H., Perry G., Smith M. A., Itoyama Y., Accelerated -synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells Brain Research 2004 1013 1 51 59 (Pubitemid 38757408)
24. Obata T., Phytic acid suppresses 1-methyl-4-phenylpyridinium ion-induced hydroxyl radical generation in rat striatum Brain Research 2003 978 1-2 241 244 (Pubitemid 36776645)
25. Blum D., Torch S., Lambeng N., Nissou M. F., Benabid A. L., Sadoul R., Verna J. M., Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease Progress in Neurobiology 2001 65 2 135 172 (Pubitemid 32524182)
26. Hanrott K., Gudmunsen L., O'Neill M. J., Wonnacott S., 6-Hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase C Journal of Biological Chemistry 2006 281 9 5373 5382 (Pubitemid 43847631)
27. Kanthasamy A. G., Anantharam V., Zhang D., Latchoumycandane C., Jin H., Kaul S., Kanthasamy A., A novel peptide inhibitor targeted to caspase-3 cleavage site of a proapoptotic kinase protein kinase C delta (PKC ) protects against dopaminergic neuronal degeneration in Parkinson's disease models Free Radical Biology and Medicine 2006 41 10 1578 1589 (Pubitemid 44528253)
28. Monteiro H. P., Winterbourn C. C., 6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation Biochemical Pharmacology 1989 38 23 4177 4182 (Pubitemid 20009013)
29. Nobre H. V., Cunha G. M. A., Maia F. D., Oliveira R. A., Moraes M. O., Rao V. S. N., Catechin attenuates 6-hydroxydopamine (6-OHDA)-induced cell death in primary cultures of mesencephalic cells Comparative Biochemistry and PhysiologyC Toxicology and Pharmacology 2003 136 2 175 180 (Pubitemid 37237552)
30. Ben-Shachar D., Eshel G., Finberg J. P. M., Youdim M. B. H., The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons Journal of Neurochemistry 1991 56 4 1441 1444 (Pubitemid 21902069)
31. Cole G. M., Ironic fate: can a banned drug control metal heavies in neurodegenerative diseases? Neuron 2003 37 6 889 890 (Pubitemid 36398293)
32. Lees G. J., Leong W., Neuronal cytotoxicity of inositol hexakisphosphate (phytate) in the rat hippocampus Brain Research 1996 741 1-2 134 141 (Pubitemid 26426308)
33. Vucenik I., Shamsuddin A. M., Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic Journal of Nutrition 2003 133 11
34. Agte V., Jahagirdar M., Chiplonkar S., Apparent absorption of eight micronutrients and phytic acid from vegetarian meals in ileostomized human volunteers Nutrition 2005 21 6 678 685 (Pubitemid 40733561)
35. Grases F., Simonet B. M., Prieto R. M., March J. G., Phytate levels in diverse rat tissues: influence of dietary phytate British Journal of Nutrition 2001 86 2 225 231 (Pubitemid 32780628)
36. Liu G., Men P., Harris P. L. R., Rolston R. K., Perry G., Smith M. A., Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance Neuroscience Letters 2006 406 3 189 193 (Pubitemid 44311364)